ABD Pediatric Dermatology common mistakes
ABD Pediatric Dermatology · Understand the traps and how to avoid them.
Committing to a single diagnosis for an infantile vascular lesion before establishing whether it is present at birth, whether it is growing, and whether it is a true hemangioma versus a vascular malformation.
Candidates pattern-match on color (red = hemangioma) and skip the natural-history questions that separate infantile hemangioma, capillary malformation, and arteriovenous malformation, which have entirely different workups and urgency.
What to do instead
For every vascular lesion, answer three questions in writing before diagnosing: present and fully formed at birth or appeared in the first weeks; proliferating or static; involuting or not. Use those answers to place the lesion in the correct category before selecting management.
Treating every infantile hemangioma as observation-only without screening for high-risk features (segmental distribution, beard/lip area, periocular location, midline lumbosacral or head/neck segmental patterns, ulceration).
The reflex 'hemangiomas involute, so reassure' is taught early and overrides the specific anatomic and morphologic red flags that mandate imaging or urgent referral.
What to do instead
Before recommending observation, run an explicit checklist: segmental morphology, location over airway/eye/lumbosacral midline, ulceration, and rapid growth. Any positive item triggers imaging or specialty referral rather than reassurance.
Diagnosing diaper dermatitis as candidiasis or as irritant contact dermatitis without first excluding a primary dermatosis (seborrheic, atopic, psoriasiform) or a systemic process (acrodermatitis enteropathica, Langerhans cell histiocytosis, immunodeficiency).
Candidal and irritant diaper dermatitis are so common that the rarer mimics are mentally filed away, and the distinguishing features (sparing of creases, satellite lesions, periorificial distribution, failure to thrive) are not actively sought.
What to do instead
For any diaper-area eruption that is persistent, atypical, or accompanied by systemic signs, document crease involvement versus sparing, presence of satellite pustules, periorificial extension, and growth/nutrition status, and list the red-flag mimics before treating.
Missing the diagnosis of atopic dermatitis by relying on a single feature rather than assembling the age-specific distribution, chronicity, and pruritus required by validated criteria.
Infant, childhood, and adolescent patterns differ (face/extensor versus flexural), and candidates apply the adult flexural template to infants or dismiss a non-flexural presentation as not atopic.
What to do instead
Apply a named criteria set explicitly (pruritus plus typical morphology and age-specific distribution plus chronicity), and state the age-specific pattern you are using to justify the diagnosis.
Failing to recognize child abuse or neglect masquerading as a dermatosis (bruising in nonmobile infants, patterned burns, immersion scald lines, unexplained genital or perianal findings, failure to thrive with rash).
The question is framed around a skin finding, so the candidate stays in a dermatologic differential and does not evaluate whether the history and developmental stage are compatible with the physical findings.
What to do instead
For any injury or unusual lesion in a young child, explicitly test the history against developmental stage (can this child cruise, climb, reach a hot surface?) and document whether the pattern is consistent with accidental injury before finalizing a dermatologic diagnosis.
Using adult dosing and adult topical potency assumptions for pediatric patients without adjusting for weight, body surface area, and percutaneous absorption risk.
Adult regimens are overlearned and pediatric pharmacokinetics are underweighted, so candidates select a potent topical steroid for the face or a fixed adult oral dose for a small child.
What to do instead
For every pediatric treatment answer, state the potency class chosen and why it is safe for the site and age, and express systemic dosing as weight-based with an explicit maximum.
Failing to obtain or interpret a medication and exposure history (new drug, supplement, contactant, or infection) before diagnosing a drug eruption, and then misclassifying the reaction pattern.
Morphology is emphasized over chronology, so candidates name a rash without establishing the temporal relationship and the specific pattern (morbilliform, urticarial, fixed, pustular, bullous) that determines risk.
What to do instead
Build the timeline first: drug start date relative to rash onset, prior exposures, mucosal involvement, and systemic signs. Then classify the eruption by pattern and flag whether it belongs to a severe cutaneous adverse reaction category requiring immediate drug withdrawal.
Under-recognizing skin manifestations of systemic or infectious disease in children (e.g., Kawasaki disease, meningococcemia, staphylococcal scalded skin, measles) because the lesion is treated as an isolated dermatologic problem.
Compartmentalizing the skin finding prevents integration with fever, mucous membrane changes, extremity changes, and lymphadenopathy that define the systemic diagnosis.
What to do instead
For any febrile child with a rash, run a structured systemic review (fever duration, conjunctival and oral findings, extremity changes, lymphadenopathy, hemodynamic status) and state which systemic diagnosis must be excluded before committing to a benign dermatosis.
Misdiagnosing pigmentary and hair/nail findings in children by applying adult paradigms (e.g., calling a congenital nevus a melanoma concern, or dismissing a hair-shaft or nail finding without considering genodermatoses and nutritional causes).
Adult melanoma anxiety and adult alopecia frameworks are overlearned, while pediatric-specific entities (congenital melanocytic nevus, alopecia areata versus tinea capitis versus trichotillomania, hair-shaft disorders, nutritional deficiency) are less rehearsed.
What to do instead
For pigmentary, hair, or nail questions, first classify by age of onset and congenital versus acquired, then list pediatric-specific differentials and specify the confirmatory test (dermoscopy, potassium hydroxide microscopy/culture, hair mount, or biopsy) that distinguishes them.
Choosing a management answer without matching it to the severity and chronicity of the condition, skipping the stepwise escalation (emollient and trigger avoidance, then topical anti-inflammatory, then systemic or phototherapy) and the maintenance-versus-flare distinction.
Candidates select the most aggressive or the most conservative option based on familiarity rather than placing the treatment on a severity-stratified algorithm, and they conflate acute flare control with long-term maintenance.
What to do instead
For every management question, state the severity tier, the first-line step for that tier, the maintenance strategy, and the explicit trigger for escalation, then select the answer that matches that ladder.